Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Fortuny

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
United European Gastroenterology Journal|January 24, 2024
Systemic therapies in hepatocellular carcinoma: A revolution?Marta Fortuny, Marco Sanduzzi-Zamparelli, Maria Reig
Cancers|June 19, 2024
Evaluation of Overall Survival by Restricted Mean Survival Time of Advanced Biliary Tract Cancer treated with Immunotherapy: A Systematic Review and Meta-AnalysisEzequiel Mauro, Marco Sanduzzi-Zamparelli, Tamara Sauri, et al.
Hepatology (Baltimore, Md.)|June 14, 2026
Beyond second-line therapy: Strategic sequencing of systemic treatments in advanced hepatocellular carcinomaMarta Fortuny, Landon L Chan, Leonardo G da Fonseca, et al.
Laboratory Animals|March 13, 2025
Impact of sex differences on the induction and evolution of clinical signs of an end-stage liver disease rat modelIgnacio Iborra, Ramon Bartoli, Ana Bargalló, et al.
Surgical Endoscopy|June 20, 2024
External validation of the SHA<sub>2</sub>PE score and its comparison to the Oakland score for the prediction of safe discharge in patients with lower gastrointestinal bleedingLaura Gonzalez-Gonzalez, Ignacio Iborra, Marta Fortuny, et al.
European Journal of Clinical Investigation|October 18, 2023
Systematic review of the role of calprotectin in cirrhosisMarta Fortuny, Maria-Rosa Sarrias, Maria Torner, et al.
Revista Espanola De Enfermedades Digestivas|July 13, 2026
Characterization of the stages of chronic liver disease based on plasma proteins involved in systemic inflammationMarta Fortuny, Maria Torner, María Bermúdez-Ramos, et al.
Hepatology (Baltimore, Md.)|December 15, 2025
Hepatocellular carcinoma with macrovascular invasion: Review and survival meta-analysis of initial local therapy using minimal prognostic criteriaMarta Fortuny, Antonio De Rosa, Ignacio Roca, et al.
Gastroenterologia Y Hepatologia|September 17, 2022
Incidence, risk factors and clinical outcomes of multidrug-resistant microorganism infections among patients admitted for decompensated cirrhosis: A prospective studyHelena Masnou, Ariadna Aguilar, Ignacio Iborra, et al.
Gastroenterologia Y Hepatologia|August 14, 2022
Appropriateness of routine pre-endoscopic SARS-CoV-2 screening with RT-PCR in asymptomatic individuals and its impact on delayed diagnosisMarta Fortuny, Ignacio Iborra, Laura Gutiérrez-Rios, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
United European Gastroenterology Journal|January 24, 2024
Systemic therapies in hepatocellular carcinoma: A revolution?Marta Fortuny, Marco Sanduzzi-Zamparelli, Maria Reig
Cancers|June 19, 2024
Evaluation of Overall Survival by Restricted Mean Survival Time of Advanced Biliary Tract Cancer treated with Immunotherapy: A Systematic Review and Meta-AnalysisEzequiel Mauro, Marco Sanduzzi-Zamparelli, Tamara Sauri, et al.
Hepatology (Baltimore, Md.)|June 14, 2026
Beyond second-line therapy: Strategic sequencing of systemic treatments in advanced hepatocellular carcinomaMarta Fortuny, Landon L Chan, Leonardo G da Fonseca, et al.
Laboratory Animals|March 13, 2025
Impact of sex differences on the induction and evolution of clinical signs of an end-stage liver disease rat modelIgnacio Iborra, Ramon Bartoli, Ana Bargalló, et al.
Surgical Endoscopy|June 20, 2024
External validation of the SHA<sub>2</sub>PE score and its comparison to the Oakland score for the prediction of safe discharge in patients with lower gastrointestinal bleedingLaura Gonzalez-Gonzalez, Ignacio Iborra, Marta Fortuny, et al.
European Journal of Clinical Investigation|October 18, 2023
Systematic review of the role of calprotectin in cirrhosisMarta Fortuny, Maria-Rosa Sarrias, Maria Torner, et al.
Revista Espanola De Enfermedades Digestivas|July 13, 2026
Characterization of the stages of chronic liver disease based on plasma proteins involved in systemic inflammationMarta Fortuny, Maria Torner, María Bermúdez-Ramos, et al.
Hepatology (Baltimore, Md.)|December 15, 2025
Hepatocellular carcinoma with macrovascular invasion: Review and survival meta-analysis of initial local therapy using minimal prognostic criteriaMarta Fortuny, Antonio De Rosa, Ignacio Roca, et al.
Gastroenterologia Y Hepatologia|September 17, 2022
Incidence, risk factors and clinical outcomes of multidrug-resistant microorganism infections among patients admitted for decompensated cirrhosis: A prospective studyHelena Masnou, Ariadna Aguilar, Ignacio Iborra, et al.
Gastroenterologia Y Hepatologia|August 14, 2022
Appropriateness of routine pre-endoscopic SARS-CoV-2 screening with RT-PCR in asymptomatic individuals and its impact on delayed diagnosisMarta Fortuny, Ignacio Iborra, Laura Gutiérrez-Rios, et al.
Pageof 2